Biohaven Pharmaceutical Holding Company Ltd. is a company in the U.S. stock market and it is a holding in 30 U.S.-traded ETFs. BHVN has around 2.9M shares in the U.S. ETF market. The largest ETF holder of BHVN is the iShares Russell 2000 ETF (IWM), with approximately 975.82K shares. Investors may also find of interest that the ETF with the largest allocation to BHVN stock is SPDR S&P Biotech ETF (XBI), with a portfolio weight of 1.07%. On average, U.S. ETFs allocate 0.21% of BHVN to their portfolios.
Additionally, BHVN is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BHVN as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 48.93%.